Pegaptanib for wet macular degeneration

Medicine & Life Sciences

• Amino Acids 5%
• Aptitude 4%
• Blood Vessels 4%
• Capillary Permeability 8%
• Developed Countries 6%
• DNA 4%
• Eye 4%
• Growth 3%
• Injections 4%
• Macular Degeneration 53%
• Molecular Structure 8%
• Motivation 5%
• Nucleic Acids 7%
• Ocular Vision 18%
• Oligonucleotides 7%
• Pathologic Neovascularization 10%
• pegaptanib 84%
• Pharmaceutical Preparations 3%
• Protein Isoforms 5%
• Proteins 5%
• RNA 5%
• Therapeutics 5%
• Vascular Endothelial Growth Factor A 18%
• Vascular Endothelial Growth Factor Receptor 8%
• Wet Macular Degeneration 100%